{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:35:55Z","timestamp":1792157755439,"version":"4.4.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi231019-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The onset age of nonalcoholic fatty liver disease (NAFLD) is decreasing, and whether earlier ages of NAFLD onset are associated with increased cancer risk is currently unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231019-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the association between NAFLD new-onset age and cancer risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231019-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study was conducted among 179\u202f328 participants included in the Kailuan Cohort Study between 2006 and 2021. In total, 46\u202f100 incident NAFLD cases were identified. For each case, a participant matched by age (older or younger by 1 year) and sex was randomly selected to create a new matched study cohort. Data were analyzed from December 2022 through April 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231019-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Onset of NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231019-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The association between the onset age of NAFLD and the risk of different cancer types was evaluated using weighted Cox regression models. Population-attributable fractions (PAFs) were used to quantify the association of NAFLD with cancer risk at different ages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231019-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 63\u202f696 participants (mean [SD] age, 51.37 [12.43] years; \u202d10\u202f932 females [17.2%] and \u202d52\u202f764 males [82.8%]), 31\u202f848 individuals had NAFLD and 31\u202f848 individuals were in the control group. During a median (IQR) follow-up of 10.16 (7.89-11.67) years, 2415 patients were diagnosed with cancer. Compared with the matched group, patients aged less than 45 years at NAFLD onset exhibited a higher risk of cancer (average hazard ratio [AHR], 1.52; 95% CI, 1.09-2.12), and as the onset age of NAFLD increased, the cancer risk decreased (ages 45-54 years: AHR, 1.50; 95% CI, 1.15-1.97; ages 55-64 years: AHR, 1.13; 95% CI, 0.97-1.33; ages &amp;amp;gt;65 years: AHR, 0.75; 95% CI, 0.45-1.27;\n                      <jats:italic>P<\/jats:italic>\n                      for interaction\u2009&amp;amp;lt;\u2009.001). Among patients aged less than 45 years at NAFLD onset, cancers were mainly digestive system and lung cancers, with AHR values of 2.00 (95% CI, 1.08-3.47) and 2.14 (95% CI, 1.05-4.36), respectively. PAFs also showed that in patients aged less than 45 years at NAFLD onset, 17.83% (95% CI, 4.92%-29.86%) of cancer risk was attributable to NAFLD.\u202c\u202c\u202c\u202c\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi231019-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study found that NAFLD was associated with increased cancer risk and there was an interaction with onset age, such that the younger the onset age of NAFLD, the greater the cancer risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.35511","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:32:18Z","timestamp":1695641538000},"page":"e2335511","source":"Crossref","is-referenced-by-count":66,"title":["New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk"],"prefix":"10.1001","volume":"6","author":[{"given":"Chenan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Song","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Genetics, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guotian","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhong","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Han","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Deng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kailuan General Hospital, Tangshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanping","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery\/Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China"},{"name":"National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Key Laboratory of Cancer Food for Special Medical Purposes for State Market Regulation, Beijing, China"},{"name":"Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"issue":"1","key":"zoi231019r1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement.","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"zoi231019r2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"zoi231019r3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus.","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"zoi231019r4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"zoi231019r5","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease.","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"issue":"4","key":"zoi231019r6","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/liv.v42.4","article-title":"Risk of hepatic and extrahepatic cancer in NAFLD: a population-based cohort study.","volume":"42","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Liver Int"},{"key":"zoi231019r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease.","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"issue":"7","key":"zoi231019r8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"issue":"5","key":"zoi231019r9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/hep.32228","article-title":"Global burden of NAFLD and chronic liver disease among adolescents and young adults.","volume":"75","author":"Paik","year":"2022","journal-title":"Hepatology"},{"issue":"6","key":"zoi231019r10","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/ijc.v150.6","article-title":"Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study.","volume":"150","author":"Liu","year":"2022","journal-title":"Int J Cancer"},{"issue":"4","key":"zoi231019r11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/jdb.2013.5.issue-4","article-title":"Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology.","volume":"5","author":"Gao","year":"2013","journal-title":"J Diabetes"},{"issue":"7","key":"zoi231019r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.19672","article-title":"Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US.","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw Open"},{"key":"zoi231019r13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.annepidem.2022.08.050","article-title":"Population attributable fraction based on marginal sufficient component cause model for mediation settings.","volume":"75","author":"Lin","year":"2022","journal-title":"Ann Epidemiol"},{"issue":"10290","key":"zoi231019r14","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"zoi231019r15","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease.","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"zoi231019r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118507","article-title":"Nonalcoholic fatty liver disease and colorectal cancer: correlation and missing links.","volume":"262","author":"Chakraborty","year":"2020","journal-title":"Life Sci"},{"issue":"2","key":"zoi231019r17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10552-018-1095-z","article-title":"Non-alcoholic fatty liver disease and colorectal cancer survival.","volume":"30","author":"Wu","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"4","key":"zoi231019r18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","article-title":"Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"issue":"10","key":"zoi231019r19","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease.","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"5","key":"zoi231019r20","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.","volume":"75","author":"Simon","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"zoi231019r21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hep.32633","article-title":"Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.","volume":"77","author":"Lin","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"zoi231019r22","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","article-title":"A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.","volume":"72","author":"Walker","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"zoi231019r23","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2337\/dc20-2375","article-title":"Associations of type 2 diabetes onset age with cardiovascular disease and mortality: The Kailuan Study.","volume":"44","author":"Zhao","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi231019r24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes.","volume":"14","author":"Lin","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"zoi231019r25","first-page":"631","article-title":"[Correlation of nonalcoholic fatty liver disease at different ages of onset with new-onset diabetes mellitus].","volume":"30","author":"Yang","year":"2022","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"12","key":"zoi231019r26","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s00125-017-4407-z","article-title":"Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.","volume":"60","author":"Schmid","year":"2017","journal-title":"Diabetologia"},{"key":"zoi231019r27","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1038\/ncomms7818","article-title":"NF?B1 is a suppressor of neutrophil-driven hepatocellular carcinoma.","volume":"6","author":"Wilson","year":"2015","journal-title":"Nat Commun"},{"key":"zoi231019r28","doi-asserted-by":"publisher","first-page":"15691","DOI":"10.1038\/ncomms15691","article-title":"Cellular senescence drives age-dependent hepatic steatosis.","volume":"8","author":"Ogrodnik","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"zoi231019r29","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/hep.31157","article-title":"Risk of cirrhosis and hepatocellular cancer in patients with NAFLD and normal liver enzymes.","volume":"72","author":"Natarajan","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"zoi231019r30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","article-title":"Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterology"},{"key":"zoi231019r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154955","article-title":"Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers.","volume":"127","author":"Liu","year":"2022","journal-title":"Metabolism"},{"issue":"4","key":"zoi231019r32","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis.","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2809840\/liu_2023_oi_231019_1695048347.70227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:32:21Z","timestamp":1695641541000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2809840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.35511","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]}}}